2214 GMT [Dow Jones]--Ord Minnett was impressed by Bubs Australia's strategy update. Still, it worries about how rising cost pressures will squeeze the dairy company's earnings. Analyst John Lawlor says key highlights of Bubs's strategy day were the introduction of its new executive leadership, the focus on growth and confirmation of FY 2026 guidance for revenues and Ebitda. "Part of the new strategy is a desire to establish U.S.-based sourcing and production which could be funded by a potential equity raise," Ord Minnett says. Still, its FY 2027 and FY 2028 Ebitda forecasts fall 10% and 20%, respectively, due to mounting cost pressures. "Given the current inflation issues, pending FDA approval and a potential equity raise, Bubs effectively remains in a holding pattern," Ord Minnett says. It retains an accumulate call. (david.winning@wsj.com; @dwinningWSJ)

(END) Dow Jones Newswires

March 26, 2026 18:20 ET (22:20 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.